From: High-dose chemotherapy with peripheral blood progenitor cell support in breast cancer: WSG AM01 and MM01
AM 01
MM01
Patients
Adjuvant N>9
M1, PR or CR after conventional
induction, ER
Arm A
Tandem-E,C,TT
STAMP V
Arm B
EC ×4 → CMF ×3
Tandem STAMP V
q2w + G-CSF
Actually randomized
368
180/480
Status
Open
Treatment related
0%
1.5%
mortality (%)